ArticleWorld journal of oncology2024

Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing.

Alexandra Lebedeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.